pargyline has been researched along with vorinostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beattie, R; Bytheway, I; Casero, RA; Crowley, ML; Hanson, A; Hazeldine, S; Hirata, A; Hirata, F; Huang, Y; Murray-Stewart, T; Senanayake, TM; Sharma, SK; Steinbergs, N; Varghese, S; Woster, PM; Wu, Y | 1 |
| Davidson, NE; Huang, Y; Katz, TA; Oesterreich, S; Vasilatos, SN; Wan, Y | 1 |
2 other study(ies) available for pargyline and vorinostat
| Article | Year |
|---|---|
Polyamine-based small molecule epigenetic modulators.
Topics: | 2012 |
Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Cadherins; Cell Line, Tumor; Cell Proliferation; Female; Genes, Tumor Suppressor; Histone Deacetylase Inhibitors; Histone Deacetylases; Histone Demethylases; Histones; Humans; Hydroxamic Acids; Membrane Proteins; Methylation; Mitochondrial Proteins; Monoamine Oxidase Inhibitors; NF-kappa B; Nuclear Receptor Subfamily 4, Group A, Member 1; Pargyline; Protocadherins; RGS Proteins; RNA Interference; RNA, Small Interfering; Vorinostat | 2013 |